Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
James Quigley is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | SNY | Buy Now | Sanofi | $55.00 | 18.18% | James Quigley26% | → $65 | Initiates | → Neutral | Get Alert |
| 11/06/2024 | KYMR | Buy Now | Kymera Therapeutics | $31.82 | 53.99% | James Quigley26% | $45 → $49 | Maintains | Equal-Weight | Get Alert |
| 09/05/2024 | NVS | Buy Now | Novartis | $111.00 | 9.01% | James Quigley26% | $119 → $121 | Downgrade | Buy → Neutral | Get Alert |
| 08/14/2024 | KYMR | Buy Now | Kymera Therapeutics | $31.82 | 41.42% | James Quigley26% | $34 → $45 | Maintains | Equal-Weight | Get Alert |
| 01/19/2024 | MOR | Buy Now | MorphoSys | — | — | James Quigley26% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/16/2024 | MOR | Buy Now | MorphoSys | — | — | James Quigley26% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/05/2023 | GRFS | Buy Now | Grifols | $7.68 | 36.72% | James Quigley26% | $10 → $10.5 | Maintains | Neutral | Get Alert |
| 11/13/2023 | KYMR | Buy Now | Kymera Therapeutics | $31.82 | -24.58% | James Quigley26% | $37 → $24 | Maintains | Equal-Weight | Get Alert |
| 10/13/2023 | MOR | Buy Now | MorphoSys | — | — | James Quigley26% | $3.7 → $9.2 | Upgrade | Underweight → Overweight | Get Alert |
| 08/29/2023 | KYMR | Buy Now | Kymera Therapeutics | $31.82 | 16.28% | James Quigley26% | $39 → $37 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | GLPG | Buy Now | Galapagos | $25.53 | 56.68% | James Quigley26% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | GLPG | Buy Now | Galapagos | $25.53 | 64.51% | James Quigley26% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | GLPG | Buy Now | Galapagos | $25.53 | 64.51% | James Quigley26% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | GLPG | Buy Now | Galapagos | $25.53 | 64.51% | James Quigley26% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | GLPG | Buy Now | Galapagos | $25.53 | 64.51% | James Quigley26% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/26/2023 | GLPG | Buy Now | Galapagos | $25.53 | 64.51% | James Quigley26% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/23/2023 | EVO | Buy Now | Evotec | $3.51 | 355.84% | James Quigley26% | $12 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 06/20/2023 | GLPG | Buy Now | Galapagos | $25.53 | 64.51% | James Quigley26% | → $42 | Reiterates | → Equal-Weight | Get Alert |
| 06/12/2023 | GLPG | Buy Now | Galapagos | $25.53 | 64.51% | James Quigley26% | → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/31/2023 | GLPG | Buy Now | Galapagos | $25.53 | 76.26% | James Quigley26% | $52 → $45 | Maintains | Neutral | Get Alert |
| 05/09/2023 | KYMR | Buy Now | Kymera Therapeutics | $31.82 | 22.56% | James Quigley26% | $41 → $39 | Maintains | Equal-Weight | Get Alert |
| 05/09/2023 | GLPG | Buy Now | Galapagos | $25.53 | 64.51% | James Quigley26% | $44 → $42 | Maintains | Equal-Weight | Get Alert |
| 04/04/2023 | EVO | Buy Now | Evotec | $3.51 | — | James Quigley26% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 08/10/2022 | EVO | Buy Now | Evotec | $3.51 | 355.84% | James Quigley26% | → $16 | Downgrade | Overweight → Underweight | Get Alert |
| 01/14/2022 | MOR | Buy Now | MorphoSys | — | — | James Quigley26% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/24/2021 | MOR | Buy Now | MorphoSys | — | — | James Quigley26% | → $28 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/25/2020 | MOR | Buy Now | MorphoSys | — | — | James Quigley26% | — | Initiates | → Equal-Weight | Get Alert |
| 11/20/2017 | ABLX | Buy Now | Ablynx NV - American Depositary Shares | — | — | James Quigley26% | → $25 | Initiates | → Overweight | Get Alert |
